SEC Form 4 · accession 0001209191-17-002556

REATA PHARMACEUTICALS INC · RETA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jan 5, 2017

Accepted (ET)

Jan 6, 2017 · 1:04 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001358762

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Class A common stock^F1	Jan 5, 2017	C	28,762	$0.00	A	59,347	D
Class A common stock^F1	Jan 5, 2017	C	38,447	$0.00	A	41,902	I	By Bass Family Trust A
Class A common stock^F1	Jan 5, 2017	C	16,107	$0.00	A	17,555	I	By Bass Trust FBO James E. Bass

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Class B common stock^F1	—	Jan 5, 2017	C	28,762	D	—	—	Class A common stock	—	D
Class B common stock^F1	—	Jan 5, 2017	C	38,447	D	—	—	Class A common stock	—	I
Class B common stock^F1	—	Jan 5, 2017	C	16,107	D	—	—	Class A common stock	—	I

F1The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time.